Breaking AI & Tech News Analyzed

The Sentencing of Matthew Perry's Former Assistant Kenneth Iwamasa, the former personal assistant to actor Matthew Perry, has been sentenced to 41 months in prison in connection with the television star's death from a fatal dose of the hallucinogenic drug ketamine. The Events Leading to Matthew Perry's Death Iwamasa had testified, as part of a plea agreement, that he injected Perry with ketamine at the actor's request on October 28, 2023, before leaving to run errands. He had no medical training. When Iwamasa returned, he found Perry's lifeless body floating in a hot tub at his home in Los Angeles's Pacific Palisades neighbourhood. Perry was 54 years old at the time. The Impact of Iwamasa's Actions Iwamasa allegedly gave Perry more than 25 shots of the drug in the days leading to his death, including three on the day he died. Court papers state that the Friends star had asked Iwamasa to 'shoot me up with a big one' in his final moments. An autopsy report found that Perry died from the 'acute effects of ketamine'. Prosecutors describe Iwamasa as Perry's 'enabler and supplier', continuing to give him injections despite troubling incidents. The Broader Investigation and Additional Convictions The sentencing of Iwamasa concludes the prosecution of five people alleged to have facilitated the actor's death by helping him access the drug without proper medical supervision. Erik Fleming, a certified drug counsellor, was sentenced to two years in prison for acting as a middleman to help supply Perry with controlled substances. Doctors Mark Chavez and Salvador Plasencia, who allegedly profited from Perry's addiction, were also convicted and sentenced in December. Jasveen Sangha, a British American woman who sold drugs to wealthy customers, was given a lengthy sentence of 15 years in prison. The Future Implications This case highlights the severe consequences of enabling and supplying controlled substances to individuals struggling with addiction. The sentencing serves as a warning to those who would seek to profit from or facilitate drug use.

The Lead Belgium and France have summoned Russia's ambassadors to express anger after Moscow urged foreigners to leave Kyiv in advance of planned 'systematic strikes'. Brussels and Paris said Russia's announcement was 'unacceptable' and a violation of international law. Diplomatic Fallout The pair are the latest of several European Union capitals to demand an explanation. Germany, the Netherlands, Norway and the European Union summoned Russian envoys on Tuesday following Moscow's warning that foreigners and diplomats should leave the Ukrainian capital before the onset of renewed air strikes. International Law Implications 'Threatening embassies is not diplomacy, it is intimidation. And it is a flagrant violation of international law and the Vienna Convention,' Belgium Foreign Minister Maxim Prevot said on Wednesday. 'Belgium is not going anywhere. We are staying in Kyiv. We are standing with Ukraine. And we will not be intimidated,' he said, adding that Russia is the sole aggressor in the Ukraine conflict, and urging Moscow to engage in 'genuine' peace talks. Escalation of Conflict Russia's Ministry of Defence issued a statement on Monday that warned it plans to launch a 'series of systematic strikes' on defence industrial facilities in Kyiv, insisting that the planned strikes would be launched in response to a Ukrainian drone attack last week that struck a student dorm in Starobilsk in the occupied Luhansk region. Future Outlook Russian President Vladimir Putin on Wednesday announced that he is open to negotiations with Europe, which could potentially lead to a resolution in the conflict. However, the EU's approach to any possible future talks remains contentious, with many EU officials and member states wary of engaging with Moscow.

The Comeback That Almost WasBritish No 4 Fran Jones delivered a performance defined by sheer grit, pushing 27th seed Marie Bouzkova to the brink of defeat in a high-stakes second-round clash at Roland Garros. Despite trailing 0-6 in the first set and 1-4 in the second, Jones refused to surrender, eventually falling 6-0, 7-6 (3). The match served as a testament to her resilience, as she fought back from a seemingly insurmountable deficit to force a tie-break.Deconstructing the Match DataRanking Disparity: Jones, ranked outside the world's top 100, faced a significant challenge against Bouzkova, a former top-10 player and consistent tour veteran.Scoreline Analysis: The 6-0, 7-6 (3) scoreline highlights a dominant first set followed by a gritty recovery in the second.Turning Point: Jones led the second-set tie-break 3-1, demonstrating her ability to compete at the highest level even when physically compromised.The Impact of Mental FortitudeWhat defines Jones is not just her heavy topspin forehand, but her "mentality monster" persona. Having overcome a rare genetic condition (ectrodactyly) and recent physical setbacks like a glute tear and concussion, her ability to maintain focus under extreme pressure is her unique selling point. Bouzkova, often described as a "gatekeeper" due to her durability, proved too consistent in the end, but Jones forced her to work for every point.Looking Ahead: The Road to WimbledonDespite the loss, Jones views this week as a stepping stone. With her sights set on the grass-court season, her confidence in her mental approach suggests she will continue to climb the rankings. Her primary focus now shifts to physical recovery and maintaining her fitness to capitalize on her formidable mindset when the tournament moves to Wimbledon.

Meta's Strategic Shift to Subscriptions Meta is doubling down on its subscription offerings, announcing the global rollout of consumer subscription plans for its flagship apps, Instagram, Facebook, and WhatsApp. The company is also beginning tests of new subscriptions for businesses, creators, and Meta AI users. Consumer Subscription Plans Consumers can subscribe to Instagram Plus ($3.99/mo), Facebook Plus ($3.99/mo), or WhatsApp Plus ($2.99/mo) to gain access to extra features, such as profile customization, super reactions, and story insights. These plans are tailored to each individual app, with Facebook Plus and Instagram Plus focused on social expression, while WhatsApp Plus focuses on personalization and messaging. The Data Behind Meta's Subscription Strategy Instagram Plus subscribers will have access to features like story insights, profile customization, and super reactions. Facebook Plus offers similar features to Instagram Plus. WhatsApp Plus provides features like app themes, custom ringtones, and additional pinned chats. The Impact on Meta's Business Model The new subscription plans aim to diversify Meta's revenue streams beyond advertising, allowing the company to extract more value from its existing audience of billions. This strategic shift comes as Meta's social apps have achieved global saturation, limiting growth opportunities. The Future of Meta's Subscription Offerings Meta will begin testing AI-focused plans, including Meta One Plus ($7.99/mo) and Meta One Premium ($19.99/mo), which offer deeper reasoning for complex tasks and more video and image-generation capabilities. The company will also test professional plans for creators and businesses, including Meta One Essential ($14.99/mo) and Meta One Advanced ($49.99/mo), which offer features like verification, impersonation protection, and enhanced analytics.

The Challenge: Designing Escape RoutesThe puzzle presents a scenario with two snakes of equal width but different lengths trapped in a cage. The objective is to design two distinct escape passages, A and B, that allow one snake to pass while blocking the other.Passage A: Must allow the short snake to escape but block the long snake.Passage B: Must allow the long snake to escape but block the short snake.The Logic of the SolutionThe solution relies on exploiting the physical dimensions of the snakes. For Passage A, the design features a loop that is longer than the short snake but shorter than the long one. When the long snake enters the loop and doubles back, its body blocks the exit point, trapping it. The short snake, being shorter, can navigate the loop without obstruction.Passage B utilizes a floor hole. Assuming the snakes have non-zero rigidity, the short snake cannot stretch far enough to move over the hole without falling in, whereas the long snake can bridge the gap and pass safely.Why Spatial Reasoning MattersThis puzzle underscores the critical role of spatial intelligence in problem-solving. It demonstrates how understanding the relationship between length, width, and path constraints can create solutions that are counter-intuitive yet logically sound.The Future of Logic Puzzles in AIAs AI models continue to advance in spatial reasoning, puzzles like this will likely serve as benchmarks for testing the flexibility of machine intelligence. The future of puzzle design may shift towards scenarios that require not just calculation, but a nuanced understanding of physical constraints.

The Lead: China's Bold Leap into Long-Duration SpaceflightChina has launched its Shenzhou-23 mission in which an astronaut will spend a full year in orbit for the first time, a crucial step in Beijing's ambition to send humans to the moon by 2030. The Long March 2-F rocket lifted off from the Jiuquan launch centre in north-western China on Sunday, carrying three astronauts to the Tiangong space station.The Mission Details: Historic Crew CompositionThe mission marks the first spaceflight ever undertaken by an astronaut from Hong Kong: Lai Ka-ying, 43, who previously worked for the territory's police. The other crew members are the space engineer Zhu Yangzhu, 39, and the former air force pilot Zhang Zhiyuan, also 39, who will be travelling into space for the first time.The Scientific Objectives: Preparing for Deep SpaceThe crew is expected to undertake numerous scientific projects in life sciences, materials science, fluid physics and medicine. A key experiment will be the full-year stay in orbit by one of the crew to study the effects of a long stay in microgravity, part of China's preparations for future lunar and possible Martian missions.Richard de Grijs, an astrophysicist and professor at Macquarie University in Australia, said the main challenges would be long-term effects on humans, including bone density loss, muscle wasting, radiation exposure, sleep disturbance and behavioural and psychological fatigue. He also underlined the importance of reliable water and air-recycling systems and the ability to manage potential medical emergencies far from Earth.The Lunar Ambitions: China's Moon RoadmapThe Shenzhou-23 mission is part of China's goal to land astronauts on the moon before 2030 in a race with Nasa's Artemis programme. Beijing is also testing the equipment required to reach its goal, with an orbital test flight of its Mengzhou spacecraft set for 2026. It will replace the ageing Shenzhou line and will carry China's astronauts to the moon.China hopes to have built the first phase of a manned scientific base, known as the International Lunar Research Station, by 2035. It also plans to welcome its first foreign astronaut, from Pakistan, to the Tiangong station by the end of this year.The Global Context: China's Space Program EvolutionBeijing has significantly expanded its space programmes over the last 30 years, injecting billions of dollars in a push to catch up with the US, Russia and Europe. It landed the Chang'e-4 probe on the far side of the moon, a world first, in 2019, and a rover on Mars in 2021.China has been formally excluded from the International Space Station since 2011, when the US banned Nasa from collaborating with Beijing, prompting it to develop its own space station project. This isolation has accelerated China's indigenous space capabilities, making the Shenzhou-23 mission a milestone in both scientific achievement and geopolitical space competition.

The LeadApple's latest MacBook Air is its most powerful yet, comes with double the starting storage and is better than ever for getting work done and as the benchmark for a consumer laptop. The Event DetailsThe M5 MacBook Air starts at £1,099 (€1,199/$1,099/A$1,799) for the 13in version, which is £100 or equivalent more than last year's excellent M4 version, but comes with at least 512GB of storage. It sits above the £599 MacBook Neo and below the £1,699 M5 MacBook Pro, making the Air Apple's mid-range machine. The Data Analysis Screen: 13.6in LCD (2560x1600; 224 ppi) True Tone Processor: Apple M5 with eight or 10-core GPU RAM: 16, 24 or 32GB Storage: 512GB, 1, 2 or 4TB SSD Operating system: macOS 26 Tahoe Camera: 12MP centre stage Connectivity: wifi 7, Bluetooth 6, 2x Thunderbolt/USB 4, headphones Dimensions: 215 x 304.1 x 11.3mm Weight: 1.23kg The Impact AnalysisThe new M5 chip marks a watershed moment for Apple's laptop line. It is about 10-20% faster than the M4 in the previous edition, which is nothing to be sniffed at. But with the progress over the last few years, the M5 makes this MacBook Air between 75% and 108% faster than the M1 MacBook Air depending on the task. The PredictionThe MacBook Air M5 is a top-notch consumer laptop that offers pro-level performance, long battery life, and sustainability features. With its improved performance, storage, and features, it is likely to remain a top choice for consumers in the market for a reliable and powerful laptop.

The Corporate AI MirageUK communications executives are reporting a surge in demand from non-tech companies to be rebranded as artificial intelligence specialists. Public relations professionals describe this trend as a desperate attempt to capitalize on the current technology buzz, often stretching the truth to secure media coverage for brands that have little genuine connection to the sector.The Mechanics of 'AI Washing'The phenomenon, often termed 'AI washing,' involves companies retrofitting the 'AI' label onto existing products or services that rely on basic automation rather than advanced generative intelligence. This rebranding effort has led to bizarre applications of the technology, such as AI-powered basketball hoops and lasers designed to protect women on underground platforms.AllBirds recently 'pivoted' to acquiring AI graphics processing units.Genetics companies are hyping AI-powered blood tests.Property firms are marketing handheld scanners that generate floor plans as AI tools.The PR Backlash and Market FatigueThe saturation of the market is causing significant friction within the PR industry. Account directors report that roughly 50% of the AI-related pitches they send out are unwanted, as journalists and executives become numb to the language. This fatigue is compounded by the skepticism surrounding claims of 'AI-driven' products that are merely better automation.Even high-profile corporate figures are under scrutiny. The chief executive of Standard Chartered recently apologized for describing workers displaced by AI as 'lower-value human capital,' highlighting the tension between corporate efficiency strategies and public perception.Future Outlook: From Hype to SubstanceWhile stock market investors have largely shrugged off recent jitters over the AI boom, the long-term viability of 'AI washing' is questionable. As the industry matures, the gap between genuine AI integration and superficial rebranding will likely widen, forcing companies to either innovate or face further reputational damage.

On 15 May, **BioOrbit** launched its compact **Box‑E** payload aboard a **SpaceX** rocket, beginning a six‑week orbital trial to grow ultra‑pure protein crystals for self‑injectable cancer therapies. Box‑E’s Orbital Test: Microgravity Enables Ultra‑Pure Protein Crystals The microwave‑sized unit will float aboard the International Space Station, where microgravity eliminates the disruptive effects of Earth’s gravity on crystal formation. The resulting crystals are more stable, allowing drug formulations that are impossible to achieve on the ground. Mission duration: ~6 weeks in orbit Target output: thousands of litres of fluid per box per year Goal: Produce cancer‑drug crystals that can be stored in a fridge and self‑injected £9.8 Million Funding Round and UK Space Agency Contract Last month **BioOrbit** closed a **£9.8 million** Series A round led by **LocalGlobe** and **Breega**, earmarked for the orbital test and scaling of the hardware. Earlier in March the company secured a **£250,000** contract from the UK Space Agency to manufacture drugs in microgravity. Potential Disruption of Cancer Treatment Delivery Current immunotherapies such as Merck’s **Keytruda** require lengthy IV infusions in hospitals. By crystallising the active protein, **Box‑E** could enable high‑concentration, low‑viscosity formulations suitable for pen‑injectors, reducing treatment time from hours to minutes and extending shelf‑life. Roadmap to Commercialisation and Market Size **BioOrbit** projects that, if orbital tests succeed, multiple **Box‑E** units could be stacked to meet the demand of a blockbuster drug within a handful of boxes. The company estimates a market of **$22.7 trillion** for in‑space manufacturing across sectors, with pharmaceuticals a key segment. Clinical trials and regulatory approval are expected to take at least five years before the new formulations reach patients. Future Outlook for Space‑Based Pharma Beyond cancer, the crystallisation platform could be applied to the roughly 70 % of top‑selling drugs that are currently administered intravenously. Partnerships with major pharma groups are already being explored, and competitors such as **Varda Space Industries** are also pursuing in‑orbit drug processing, signaling a burgeoning industry.